Literature DB >> 1738193

Identification of a novel gene, Vin-1, in murine leukemia virus-induced T-cell leukemias by provirus insertional mutagenesis.

P J Tremblay1, C A Kozak, P Jolicoeur.   

Abstract

The BL/VL3 radiation leukemia virus is a nondefective retrovirus which induces clonal or oligoclonal T-cell leukemia in mice. To study the role of provirus insertional mutagenesis in the development of these neoplasias, we searched for common provirus integration sites in BL/VL3 radiation leukemia virus-induced tumors. Using cellular sequences flanking a provirus cloned from one of these thymomas, we found that the viral genome was integrated into a common region, designated Vin-1, in a low percentage (5%) of these tumors. The proviruses found in this locus were integrated in the same orientation, close to a CpG-rich island, at proximity of a transcriptional unit encoding a 6-kb RNA. Vin-1 RNA was detected in several organs of the adult mouse. Vin-1 RNA levels were high in tumors having a provirus inserted within the Vin-1 region but were also high in some other tumors whose Vin-1 region was not found to be rearranged. Vin-1 was found to be well conserved among mammalian species and was mapped to mouse chromosome 6, between raf and K-ras-2. Vin-1 appears to be a novel gene which may be involved in tumor development.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1738193      PMCID: PMC240856     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  THE ROLE OF RADIATION ON EXPERIMENTAL LEUKEMOGENESIS.

Authors:  H S KAPLAN
Journal:  Natl Cancer Inst Monogr       Date:  1964-05

Review 2.  Oncogenes at viral integration sites.

Authors:  G Peters
Journal:  Cell Growth Differ       Date:  1990-10

3.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

4.  Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor.

Authors:  R G Goodwin; D Anderson; R Jerzy; T Davis; C I Brannan; N G Copeland; N A Jenkins; C A Smith
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

Review 5.  CpG-rich islands and the function of DNA methylation.

Authors:  A P Bird
Journal:  Nature       Date:  1986 May 15-21       Impact factor: 49.962

6.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

7.  Important role of the long terminal repeat of the helper Moloney murine leukemia virus in Abelson virus-induced lymphoma.

Authors:  P Savard; L DesGroseillers; E Rassart; Y Poirier; P Jolicoeur
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

8.  Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.

Authors:  M van Lohuizen; S Verbeek; P Krimpenfort; J Domen; C Saris; T Radaszkiewicz; A Berns
Journal:  Cell       Date:  1989-02-24       Impact factor: 41.582

9.  Identification of a common helper provirus integration site in Abelson murine leukemia virus-induced lymphoma DNA.

Authors:  Y Poirier; C Kozak; P Jolicoeur
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

10.  A new site of integration for mouse mammary tumor virus proviral DNA common to BALB/cf(C3H) mammary and kidney adenocarcinomas.

Authors:  M Garcia; R Wellinger; A Vessaz; H Diggelmann
Journal:  EMBO J       Date:  1986-01       Impact factor: 11.598

View more
  12 in total

Review 1.  Mouse chromosome 6.

Authors:  R W Elliott; K J Moore
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  Gris1, a new common integration site in Graffi murine leukemia virus-induced leukemias: overexpression of a truncated cyclin D2 due to alternative splicing.

Authors:  Catherine Denicourt; Christine A Kozak; Eric Rassart
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Transcriptional up-regulation of the cyclin D2 gene and acquisition of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1-infected cells.

Authors:  F Santiago; E Clark; S Chong; C Molina; F Mozafari; R Mahieux; M Fujii; N Azimi; F Kashanchi
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice.

Authors:  B Scheijen; J Jonkers; D Acton; A Berns
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  Selection for c-myc integration sites in polyclonal T-cell lymphomas.

Authors:  Dana R Broussard; Jennifer A Mertz; M Lozano; Jaquelin P Dudley
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

6.  Radiation leukemia virus common integration at the Kis2 locus: simultaneous overexpression of a novel noncoding RNA and of the proximal Phf6 gene.

Authors:  Séverine Landais; Renaud Quantin; Eric Rassart
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  The murine AIDS defective provirus acts as an insertional mutagen in its infected target B cells.

Authors:  M Huang; M Takac; C A Kozak; P Jolicoeur
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

8.  Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesis.

Authors:  Carla P Martins; Anton Berns
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

9.  Walleye retroviruses associated with skin tumors and hyperplasias encode cyclin D homologs.

Authors:  L A LaPierre; J W Casey; D L Holzschu
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

Review 10.  D-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cells.

Authors:  Qian Zhang; Kazuhito Sakamoto; Kay-Uwe Wagner
Journal:  Mol Cell Endocrinol       Date:  2013-04-04       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.